WO2024185843A1 - Animal cell culturing method - Google Patents

Abstract

The present invention provides: a method for culturing animal cells in the presence of lecithin; and a technology related thereto.

Description

Method for culturing animal cells

The present invention relates to a method for culturing animal cells and related techniques.

Culture media containing serum such as fetal bovine serum are widely used for culturing animal cells. However, from the standpoint of safety and economics, there is a demand for the development of serum-free culture media. For example, serum-free culture media have been developed in which serum is replaced with alternative components such as growth factors (Non-Patent Document 1).

Lecithin is sometimes used for culturing animal cells (Patent Documents 1 and 2).

Journal of Bioengineering, Vol. 100, No. 4, 165-168. 2022

Japanese Patent Publication No. 58-013389 Japanese Patent Publication No. 07-231783

The objective of the present invention is to provide a method for culturing animal cells and related techniques.

The inventors discovered that animal cells can be cultured in the absence of serum by using lecithin, and thus completed the present invention.

That is, the present invention can be exemplified as follows.
[1]
A method for culturing animal cells, comprising:
The composition, wherein the animal is a meat animal.
[2]
The composition (specifically, the composition described in [1]) above, which is a composition for improving the growth of animal cells.
[3]
The composition (specifically described in [1] or [2]) which is a medium or a medium additive.
[4]
The composition (specifically described in [3]) wherein the medium is a basal medium, a feed medium, or a perfusion medium.
[5]
The composition (specifically, any one of [1] to [4]) wherein the lecithin is soybean lecithin.
[6]
The composition (specifically, any one of [1] to [5]) further contains a pea-derived material.
[7]
The composition (specifically as described in [6]) wherein the pea-derived material is a pea fermentation product and/or pea protein.
[8]
The composition (specifically described in [7]) wherein the fermented pea product is pea soy sauce.
[9]
The composition (specifically, any one of [1] to [8]) wherein the animal is a mammal, a bird, a fish, or a crustacean.
[10]
The composition (specifically, any one of [1] to [9]) wherein the animal is a cow.
[11]
The composition (specifically, the composition described in any one of [1] to [10]) which is substantially free of serum.
[12]
The composition (specifically, any one of [1] to [11]) which is substantially free of animal-derived albumin.
[13]
A method for producing a product, comprising the steps of:
Cultivating animal cells in the presence of lecithin,
The method, wherein the animal is a meat animal.
[14]
The method (specifically described in [13]) wherein the product is cultured meat.
[15]
1. A method for culturing animal cells, comprising the steps of:
Cultivating animal cells in the presence of lecithin,
The method, wherein the animal is a meat animal.
[16]
1. A method for enhancing growth of an animal cell, comprising:
Cultivating animal cells in the presence of lecithin,
The method, wherein the animal is a meat animal.
[17]
The method (specifically, the method according to any one of [13] to [16]) wherein the lecithin is soybean lecithin.
[18]
The method (specifically, the method according to any one of [13] to [17]), wherein the concentration of the lecithin in the medium during the culture is 0.1 to 100 μg/mL.
[19]
The method (specifically, any one of [13] to [18]) wherein the culture is carried out in the presence of a pea-derived material.
[20]
The method (specifically described in [19]) wherein the pea-derived material is a pea fermentation product and/or pea protein.
[21]
The method (specifically described in [20]) wherein the fermented pea product is pea sauce.
[22]
The method (specifically described in [20] or [21]) wherein the concentration of the pea fermentation product in the medium during the culture is 0.1 to 100 mg/mL.
[23]
The method (specifically, any one of [20] to [22]) described above, wherein the concentration of the pea protein in the medium during the culture is 0.05 to 50 mg/mL.
[24]
The method (specifically, any one of [13] to [23]) described above, wherein the animal is a mammal, a bird, a fish, or a crustacean.
[25]
The method (specifically, the method according to any one of [13] to [24]) wherein the animal is a cow.
[26]
The method (specifically, the method according to any one of [13] to [25]), wherein the culture is carried out in a medium that is substantially free of serum.
[27]
The method (specifically, the method according to any one of [13] to [26]), wherein the culture is carried out in a medium substantially free of animal-derived albumin.

According to the present invention, animal cells can be cultured.

FIG. 1 shows the proliferation of bovine muscle stem cells in serum-free medium in the presence of soy lecithin. FIG. 1 shows the proliferation rate of bovine muscle stem cells in serum-free medium in the presence of soy lecithin. FIG. 1 shows the proliferation of bovine muscle stem cells in serum-free medium in the presence of pea sauce and a combination of pea protein and soy lecithin. FIG. 1 shows the proliferation rate of bovine muscle stem cells in serum-free medium in the presence of pea sauce and a combination of pea protein and soy lecithin.

<1> Active Ingredient <1-1> Active Ingredient In the present invention, lecithin is used as an active ingredient.

Lecithin is also called the "active ingredient."

The active ingredient can be used to culture animal cells. Specifically, animal cells can be cultured in the presence of the active ingredient.

The use of an active ingredient, specifically by culturing animal cells in the presence of the active ingredient, may improve the growth of the animal cells, i.e., an effect of improving the growth of the animal cells may be obtained. This effect is also called a "growth improving effect." In other words, the active ingredient may have a function of improving the growth of the animal cells. This function is also called a "growth improving function." In other words, by culturing the animal cells in the presence of the active ingredient, the growth of the animal cells may be improved compared to the case where the animal cells are cultured in the absence of the active ingredient. An example of a case where the animal cells are cultured in the absence of the active ingredient is a case where the animal cells are cultured under the same conditions as the case where the animal cells are cultured in the presence of the active ingredient, except that the active ingredient is not used. The growth improving effect may be obtained, for example, when the animal cells are cultured in the substantial absence of serum (i.e., when the animal cells are cultured in a medium that is substantially free of serum). The growth improving effect may be obtained, for example, when the animal cells are cultured in the substantial absence of animal-derived albumin (i.e., when the animal cells are cultured in a medium that is substantially free of animal-derived albumin). The growth-enhancing effect may be obtained, for example, when the animal cells are cultured in conditions substantially free of serum and animal-derived albumin (i.e., when the animal cells are cultured in a medium substantially free of serum and animal-derived albumin). Growth enhancement includes an increase in the proliferation rate. The growth-enhancing effect can be confirmed by measuring and comparing the growth (e.g., proliferation rate) of the animal cells in the presence and absence of the active ingredient.

In one aspect, a product may be produced by culturing animal cells. Examples of the product include cultured meat and target substances. The target substance is not particularly limited as long as it can be produced by animal cells. Examples of the target substance include proteins and viruses. Examples of the product include cultured meat. When a product is produced by culturing animal cells, the production of the product may be improved by using an active ingredient. That is, by culturing the animal cells in the presence of the active ingredient, the production of the product may be improved compared to the case where the animal cells are cultured in the absence of the active ingredient. For example, the production of the product may be improved by improving the growth of the animal cells by using the active ingredient. That is, one aspect of the growth improvement effect may be the effect of improving the production of the product. The effect of improving the production of the product may be obtained, for example, when the animal cells are cultured under conditions substantially free of serum (i.e., when the animal cells are cultured in a medium substantially free of serum). The effect of improving the production of the product may be obtained, for example, when the animal cells are cultured under conditions substantially free of animal-derived albumin (i.e., when the animal cells are cultured in a medium substantially free of animal-derived albumin). The effect of improving the production of a product may be obtained, for example, when the animal cells are cultured under conditions substantially free of serum and animal-derived albumin (i.e., when the animal cells are cultured in a medium substantially free of serum and animal-derived albumin). Examples of the improvement in production include an improvement in the production amount and an improvement in the production rate.

The term "cultured meat" is used herein to describe meat that is grown from in vitro non-human animal cell cultures rather than from slaughtered animals. Additional terms that can be used in the art to describe meat grown from in vitro animal cell cultures include lab-grown meat, clean meat, in vitro meat, cell-based meat, cell-based meat products, and synthetic meat.

"Lecithin" may be a general term for materials containing phospholipids. Lecithin may contain phospholipids as a main component. The phospholipid content in lecithin may be, for example, 50% (w/w) or more, 70% (w/w) or more, 90% (w/w) or more, or 95% (w/w) or more. The type of lecithin is not particularly limited as long as it has the desired function (e.g., growth-improving function). Examples of lecithin include vegetable lecithin, egg yolk lecithin, and derivatives thereof. Examples of vegetable lecithin include soybean lecithin, rapeseed lecithin, and sunflower lecithin. Examples of derivatives include fractionated lecithin, enzyme-treated lecithin, and enzyme-decomposed lecithin. Examples of lecithin include soybean lecithin. As for the lecithin, one type of lecithin may be used, or two or more types of lecithin may be used in combination.

As the lecithin, a commercially available product may be used, or one obtained by appropriate production may be used. There are no particular limitations on the method for producing lecithin. For example, lecithin can be produced by separation from a raw material containing lecithin. Specifically, soybean lecithin can be produced by separation from soybean oil. In this specification, soybean lecithin refers to a composition containing phospholipids as the main component produced from soybeans as a raw material, and may also include those derived from raw materials other than soybeans, so long as they are phospholipid-containing compositions having the same composition as the composition.

The amount of lecithin can be determined by molybdenum blue spectrophotometry after ashing the sample. If necessary, the amount of lecithin can be determined after fractionating the sample by thin layer chromatography. In this specification, the amount of lecithin is calculated as the quantitative value of phospholipids.

<1-2> Other Ingredients The active ingredient may be used in combination with other ingredients, for example. Examples of the other ingredients include pea-derived materials and yeast extract. That is, the active ingredient may be used in combination with, for example, pea-derived materials and/or yeast extract. Examples of the other ingredients include, in particular, pea-derived materials. That is, the active ingredient may be used in combination with, in particular, at least, pea-derived materials. The other ingredients (for example, pea-derived materials and yeast extract) may have, for example, a growth-promoting function. With regard to the growth-promoting function of the other ingredients, the description of the growth-promoting function of the active ingredient may be applied mutatis mutandis.

<1-2-1> Pea-derived material "Pea-derived material" means a material derived from peas.

The type of pea-derived material is not particularly limited. For example, a pea-derived material having a desired function (e.g., growth-improving function) may be selected. Examples of pea-derived materials include processed pea products. Examples of pea-derived materials (e.g., processed pea products) include fermented pea products and pea proteins. As the pea-derived material, one type of material may be used, or two or more types of materials may be used in combination.

The type of pea is not particularly limited. The pea may be selected from those which provide a pea-derived material having the desired function (for example, growth-improving function). Examples of peas include peas and snow peas. Examples of peas include mature peas such as green peas, red peas, and yellow peas, and immature peas such as green peas. Examples of peas include peas in particular. Examples of peas include mature peas. Examples of peas include peas in particular. As peas, one type of pea may be used, or two or more types of peas may be used in combination. That is, the pea-derived material may be derived from one type of pea, or two or more types of peas. That is, as the pea-derived material, a material derived from one type of pea may be used, or two or more types of peas may be used in combination.

<1-2-1-1> Fermented pea product The term "fermented pea product" refers to a product obtained by fermenting peas with a microorganism. "Fermentation" here may refer to use as a medium component in culture. That is, "fermenting peas with a microorganism" may refer to culturing a microorganism in a medium containing peas. That is, the term "fermented pea product" specifically refers to a product obtained by culturing a microorganism in a medium containing peas. As the fermented pea product, one type of fermented product may be used, or two or more types of fermented products may be used in combination.

The type of pea from which the pea fermented product is derived is not particularly limited, so long as the pea fermented product can be produced. The peas are as described above. The pea fermented product may be derived from one type of pea, or from two or more types of peas. In other words, the pea fermented product may be a fermented product derived from one type of pea, or a combination of fermented products derived from two or more types of peas.

An example of a fermented pea product is pea soy sauce. "Pea soy sauce" may mean a soy sauce-like seasoning produced using peas as a raw material. "Soy sauce-like seasoning" may mean a liquid seasoning or a processed product thereof that can be used for the same purposes as "soy sauce" as specified by the Japanese Agricultural Standards. Processed products include dried products (e.g., dried powder). An example of pea soy sauce is one produced by the method described in JP 2014-110771 A.

Below, an example of a method for producing a fermented pea product is given. In other words, the fermented pea product may be produced by this production method.

Fermented peas can be produced by fermenting peas with microorganisms (specifically, by culturing the microorganisms in a medium containing peas).

In other words, first, a microorganism may be cultured in a medium containing peas. That is, the method for producing a fermented pea product may include a step of culturing a microorganism in a medium containing peas. This step is also referred to as a "cultivation step." Specifically, the culture step may be a step of culturing a microorganism in a medium containing peas to obtain a culture product. This culture is also referred to as a "fermentation product."

The type of microorganism is not particularly limited as long as it is capable of producing a fermented pea product. Examples of the microorganism include bacteria and fungi.

Bacteria include lactic acid bacteria.

Lactic acid bacteria include Tetragenococcus halophilus and other Tetragenococcus genus bacteria, Bifidobacterium longum, Bifidobacterium breve, Bifidobacterium bifidum, Bifidobacterium adolescentis, Bifidobacterium angulatum, Bifidobacterium dentium, Bifidobacterium pseudocatenulatum, Bifidobacterium animalis, Examples of bacteria that may be included include Bifidobacterium pseudolongum, Bifidobacterium thermophilum, and other Bifidobacterium genus bacteria, and Lactobacillus mali, Lactobacillus hilgardii, Lactobacillus Brevis, Lactobacillus delbrueckii, Lactobacillus casei, Lactobacillus paracasei, Lactobacillus gasseri, and Lactobacillus acidophilus, and other Lactobacillus genus bacteria. Lactic acid bacteria may in particular be bacteria of the genus Tetragenococcus. Lactic acid bacteria may more particularly be Tetragenococcus halophilus. The lactic acid bacteria may, for example, be halotolerant lactic acid bacteria. "Halotolerant lactic acid bacteria" may, for example, mean lactic acid bacteria capable of growing in a medium containing 8% (w/w) sodium chloride. For example, Tetragenococcus halophilus may be an example of a halotolerant lactic acid bacteria. As the lactic acid bacteria, for example, lactic acid bacteria commonly used in the production of soy sauce may be selected.

Fungi include yeasts and filamentous fungi.

The yeast may be budding yeast or fission yeast. The yeast may be haploid, diploid or higher polyploid yeast. Examples of yeast include yeasts of the genus Zygosaccharomyces, such as Zygosaccharomyces rouxii and Zygosaccharomyces sapae, yeasts of the genus Saccharomyces, such as Saccharomyces cerevisiae, yeasts of the genus Pichia farinosa, Pichia ciferrii, Pichia sydowiorum, Pichia pastoris, and yeasts of the genus Pichia spp. oris, yeasts of the genus Candida, such as Candida versatilis, Candida etschelsii, and Candida utilis, yeasts of the genus Hansenula, such as Hansenula polymorpha, and yeasts of the genus Schizosaccharomyces, such as Schizosaccharomyces pombe. Examples of yeasts include, in particular, Zygosaccharomyces rouxii, Zygosaccharomyces sapae, Pichia farinosa, Candida versatilis, Candida etschelsii, Saccharomyces cerevisiae, and Schizosaccharomyces pombe. Examples of yeasts include, in particular, yeasts of the genus Zygosaccharomyces. Examples of yeasts include, in particular, Zygosaccharomyces rouxii. An example of Zygosaccharomyces rouxii is Zygosaccharomyces rouxii NBRC 1130 strain (ATCC 56077). An example of Saccharomyces cerevisiae is Saccharomyces cerevisiae NBRC 10217 strain (ATCC 18824), BY4742 strain (ATCC 201389), BY4743 strain (ATCC 201390), and S288C strain (ATCC 26108). An example of Schizosaccharomyces pombe is Schizosaccharomyces pombe NBRC 1628 strain. The yeast may be, for example, a salt-tolerant yeast. "Salt-tolerant yeast" may mean, for example, a yeast capable of growing in a medium containing 8% (w/w) sodium chloride. For example, Zygosaccharomyces rouxii, Zygosaccharomyces sapae, Pichia farinosa, Candida versatilis, and Candida etschelsii may all be examples of salt-tolerant yeasts. The yeast may be selected, for example, from yeasts commonly used in the production of soy sauce.

Examples of filamentous fungi include fungi of the genus Aspergillus, such as Aspergillus oryzae, Aspergillus sojae, Aspergillus niger, Aspergillus tamarii, Aspergillus kawachii, Aspergillus awamori, and Aspergillus saitoi. Examples of filamentous fungi include Aspergillus oryzae and Aspergillus sojae in particular. As filamentous fungi, for example, filamentous fungi commonly used in soy sauce production (specifically, koji production) may be selected.

These strains can be obtained, for example, from the American Type Culture Collection (ATCC, Address: 10801 University Boulevard Manassas, VA 20110, United States of America). That is, each strain is assigned a registration number, and can be obtained by using this registration number (see http://www.atcc.org/). The registration number corresponding to each strain is listed in the catalog of the American Type Culture Collection. These strains can also be obtained, for example, from the NBRC (NITE Biological Resource Center). These strains can also be obtained, for example, from the depository institution where each strain has been deposited.

As the microorganism, one type of microorganism may be used, or two or more types of microorganisms may be used in combination. As the microorganism, for example, a filamentous fungus, yeast, and lactic acid bacteria may be used in combination. When two or more types of microorganisms are used in combination, the microorganisms may or may not be cultured simultaneously. For example, a filamentous fungus may be cultured first, and then yeast and lactic acid bacteria may be cultured. Note that when a certain microorganism A is cultured first, and then a certain microorganism B is cultured, the "peas" in the culture of microorganism B may mean the peas after the culture of microorganism A (i.e., the peas after fermentation by microorganism A).

The culture conditions are not particularly limited as long as a fermented pea product can be produced. The culture can be carried out, for example, under normal conditions used for culturing microorganisms, except for using a medium containing peas. The culture can be carried out, for example, by solid culture (i.e., in a solid medium) or by liquid culture (i.e., in a liquid medium). The culture can particularly be carried out by liquid culture (i.e., in a liquid medium).

The medium used for the culture is not particularly limited as long as it contains peas and can produce a fermented pea product. The medium may contain, in addition to peas, a carbon source, a nitrogen source, a phosphate source, a sulfur source, and other components selected from various organic and inorganic components as necessary. The medium may be peas themselves. That is, microorganisms may be directly inoculated into peas and cultured. The types and concentrations of medium components can be appropriately set by those skilled in the art. For specific medium compositions, reference may be made to, for example, the composition of ordinary mediums used for culturing microorganisms. The medium may contain one type of pea, or a combination of two or more types of peas.

　There are no particular limitations on the manner in which peas are used in the culture, so long as a fermented pea product can be produced. For example, peas may be used in the culture after being separated from the pods, or they may be used in the culture without being separated from the pods. As for peas, for example, fresh products (specifically, the edible parts of fresh products) may be used in the culture either as is or after suitable processing. Examples of processing include cutting, crushing, straining, squeezing, fractionating, diluting, concentrating, drying, and heating. These processes may be carried out alone or in suitable combinations.

Carbon sources include sugars. Specific examples of sugars include glucose, fructose, galactose, xylose, arabinose, sucrose, lactose, cellobiose, blackstrap molasses, starch hydrolysates, and biomass hydrolysates. As the carbon source, one type of carbon source may be used, or two or more types of carbon sources may be used in combination.

Specific examples of nitrogen sources include ammonium salts such as ammonium sulfate, ammonium chloride, and ammonium phosphate; organic nitrogen sources such as peptone, casein peptone, soy peptone, potato peptone, wheat peptone, casamino acids, yeast extract, malt extract, meat extract, and corn steep liquor; ammonia, and urea. As the nitrogen source, one type of nitrogen source may be used, or two or more types of nitrogen sources may be used in combination.

Specific examples of phosphate sources include phosphate salts such as potassium dihydrogen phosphate and dipotassium hydrogen phosphate, and phosphate polymers such as pyrophosphate. As the phosphate source, one type of phosphate source may be used, or two or more types of phosphate sources may be used in combination.

Specific examples of sulfur sources include inorganic sulfur compounds such as sulfates, thiosulfates, and sulfites, and sulfur-containing amino acids such as cysteine, cystine, and glutathione. As the sulfur source, one type of sulfur source may be used, or two or more types of sulfur sources may be used in combination.

Specific examples of other various organic and inorganic components include inorganic salts such as sodium chloride and potassium chloride; trace metals such as iron, manganese, magnesium, and calcium; vitamins such as vitamin B1, vitamin B2, vitamin B6, nicotinic acid, nicotinamide, and vitamin B12; amino acids; nucleic acids; and organic components containing these, such as peptone, casamino acids, yeast extract, malt extract, meat extract, and corn steep liquor. As other various organic and inorganic components, one type of component may be used, or two or more types of components may be used in combination.

The medium may, for example, contain at least sodium chloride. That is, the medium may, for example, contain peas and sodium chloride.

Cultivation may be carried out, for example, under aerobic conditions. In the case of aerobic conditions, the dissolved oxygen concentration of the medium may be controlled, for example, to 5 to 50%, preferably 10 to 20%, as a ratio of the saturated dissolved oxygen concentration of 100%. Specifically, the cultivation under aerobic conditions may be carried out, for example, by static cultivation, aeration cultivation, shaking cultivation, stirring cultivation, or a combination thereof. The cultivation temperature may be, for example, 25 to 45°C, 25 to 35°C, preferably 27°C to 33°C, more preferably 28°C to 32°C. The cultivation period may be, for example, 10 hours to 6 months, 10 hours to 2 months, 10 hours to 1 month, 10 hours to 200 hours, preferably 15 hours to 120 hours. The pH of the medium may be, for example, pH 3 to 10, preferably pH 3 to 8. The pH of the medium may be adjusted as necessary during the cultivation. To adjust the pH, inorganic or organic acidic or alkaline substances such as ammonia gas can be used. The culture may be performed, for example, by batch culture, fed-batch culture, continuous culture, or a combination of these. The culture may also be divided into a preculture and a main culture. For example, the preculture may be performed on a solid medium such as an agar medium, and the main culture may be performed in a liquid medium. Note that "the medium contains a certain component" means that, when the culture is divided into a seed culture and a main culture, the medium contains the component at least during the main culture. That is, for example, peas are contained in the medium at least during the main culture. The culture may be continued, for example, until a culture having a desired function (for example, a growth-improving function) is obtained.

The cultivation can be carried out, for example, in the manner described in JP 2014-110771 A. That is, for example, first, peas that have been appropriately pretreated are inoculated with a filamentous fungus and cultivated to produce pea koji. The cultivation for producing pea koji may be carried out, for example, at 25-45°C and a humidity of 85-95%, for 12-240 hours. Next, the pea koji is mixed with an aqueous sodium chloride solution, and yeast and lactic acid bacteria are inoculated to carry out cultivation (specifically, maturation), to produce a fermented product. The maturation may be carried out, for example, at 15-35°C for 3-6 months with appropriate stirring. The maturation may be carried out, for example, at 35-55°C for 1 day to 2 months with appropriate stirring.

The amount of peas, sodium chloride, and other medium components in the medium is not particularly limited, as long as it is possible to produce a fermented pea product.

The pea content in the medium may be, for example, 0.5% (w/w) or more, 1% (w/w) or more, 2% (w/w) or more, 3% (w/w) or more, 4% (w/w) or more, 5% (w/w) or more, 7% (w/w) or more, 10% (w/w) or more, 15% (w/w) or more, 20% (w/w) or more, 25% (w/w) or more, 30% (w/w) or more, 40% (w/w) or more, 50% (w/w) or more, or 70% (w/w) or more; It may be 100% (w/w) or less, 70% (w/w) or less, 50% (w/w) or less, 40% (w/w) or less, 30% (w/w) or less, 25% (w/w) or less, 20% (w/w) or less, 15% (w/w) or less, 10% (w/w) or less, 7% (w/w) or less, 5% (w/w) or less, 4% (w/w) or less, 3% (w/w) or less, 2% (w/w) or less, or 1% (w/w) or less, or any non-consistent combination thereof. The content of peas in the medium may in particular be, for example, 0.5-1% (w/w), 1-2% (w/w), 2-3% (w/w), 3-4% (w/w), 4-5% (w/w), 5-7% (w/w), 7-10% (w/w), 10-15% (w/w), 15-20% (w/w), 20-25% (w/w), 25-30% (w/w), 30-40% (w/w), 40-50% (w/w), 50-70% (w/w) or 70-100% (w/w). The content of peas in the medium may be, for example, 0.5 to 100% (w/w), 0.5 to 50% (w/w), 1 to 30% (w/w), or 2 to 10% (w/w).

The sodium chloride content in the medium may be, for example, 0% (w/w) or more, 0.1% (w/w) or more, 0.2% (w/w) or more, 0.5% (w/w) or more, 1% (w/w) or more, 2% (w/w) or more, 3% (w/w) or more, 4% (w/w) or more, 5% (w/w) or more, 6% (w/w) or more, 7% (w/w) or more, 8% (w/w) or more, 9% (w/w) or more, 10% (w/w) or more, 12% (w/w) or more, or 15% (w/w) or more, It may be 20% (w/w) or less, 15% (w/w) or less, 12% (w/w) or less, 10% (w/w) or less, 9% (w/w) or less, 8% (w/w) or less, 7% (w/w) or less, 6% (w/w) or less, 5% (w/w) or less, 4% (w/w) or less, 3% (w/w) or less, 2% (w/w) or less, 1% (w/w) or less, 0.5% (w/w) or less, 0.2% (w/w) or less, or 0.1% (w/w) or less, or any non-consistent combination thereof. The content of sodium chloride in the medium may be, specifically, for example, 0-0.1% (w/w), 0.1-0.2% (w/w), 0.2-0.5% (w/w), 0.5-1% (w/w), 1-2% (w/w), 2-3% (w/w), 3-4% (w/w), 4-5% (w/w), 5-6% (w/w), 6-7% (w/w), 7-8% (w/w), 8-9% (w/w), 9-10% (w/w), 10-12% (w/w), 12-15% (w/w), or 15-20% (w/w). The sodium chloride content in the medium may be, for example, 0-20% (w/w), 0.1-20% (w/w), 1-20% (w/w), 5-20% (w/w), 5-15% (w/w), or 5-12% (w/w). The "0% (w/w) or more" content of sodium chloride in the medium includes the case where the medium does not contain sodium chloride (i.e., 0% (w/w)) and the case where the medium contains sodium chloride (i.e., more than 0% (w/w)). Thus, for example, "the sodium chloride content in the medium is 0-20% (w/w)" means that the medium does not contain sodium chloride or that the medium contains sodium chloride at a content of 20% (w/w) or less (specifically, a content of more than 0% (w/w) and less than 20% (w/w)).

Any of the medium components, such as peas and sodium chloride, may be contained in the medium throughout the entire culture period, or may be contained in the medium only during part of the culture period. In other words, "culture is carried out in a medium containing a certain component" means that the component is contained in the medium during at least part of the culture period, and does not require that the component be contained in the medium throughout the entire culture period. Any of the medium components, such as peas and sodium chloride, may be contained in the medium at the start of culture, or may be supplied to the medium after the start of culture. Any of the medium components, such as peas and sodium chloride, may be contained in the medium at the start of culture, and may be further supplied to the medium after the start of culture (e.g., after the component is consumed).

All medium components such as peas and sodium chloride may be contained in the medium at the concentrations exemplified above, for example, during the entire culture period, or may be contained in the medium at the concentrations exemplified above only during a part of the culture period. In other words, "culture is carried out in a medium containing a certain component at a certain concentration" means that the concentration of the component in the medium is within that range during at least a part of the culture period, and does not require that the concentration of the component in the medium is within that range during the entire culture period. All medium components such as peas and sodium chloride may be contained in the medium at the concentrations exemplified above, for example, at the start of culture, or may be supplied to the medium after the start of culture to reach the concentrations exemplified above. All medium components such as peas and sodium chloride may be contained in the medium at the concentrations exemplified above, for example, at the start of culture, and may be further supplied to the medium after the start of culture (for example, after the component is consumed) to reach the concentrations exemplified above.

The length of the "part of the culture period" is not particularly limited as long as it is possible to produce a pea fermented product. The length of the "part of the culture period" can be set appropriately depending on various conditions such as the type of medium components, the type of microorganism, and the length of the culture period. The "part of the culture period" may be, for example, 10% or more, 20% or more, 30% or more, 40% or more, 50% or more, 60% or more, 70% or more, 80% or more, 90% or more, 95% or more, 97% or more, or 99% or more of the entire culture period. In addition, the "part of the culture period" may be, for example, 10 hours or more, 20 hours or more, 40 hours or more, 60 hours or more, 80 hours or more, 100 hours or more, 120 hours or more, or 150 hours or more. In addition, when the culture is divided into a seed culture and a main culture, the "entire culture period" means the entire period of the main culture.

By culturing the microorganisms in this manner, a culture (i.e. pea fermentate) is obtained.

The culture may be used as a pea fermented product as it is, or after being subjected to an appropriate treatment. That is, the method for producing a pea fermented product may include a step of subjecting the culture to a treatment. For example, the culture may be used as a pea fermented product in the production of the composition of the present invention, as it is, or after being subjected to an appropriate treatment. Also, for example, the culture may be used as a pea fermented product in the method of the present invention, as it is, or after being subjected to an appropriate treatment. The treatment is not particularly limited as long as the object of the present invention can be achieved (for example, a growth-improving effect can be obtained). Examples of the treatment include fractionation, dilution, concentration, drying, heating, and sterilization. For example, in the case of fractionation, a fraction having a desired function (for example, a growth-improving function) may be collected. The fraction collected by fractionation may specifically be a fraction containing a component having a desired function (for example, a growth-improving function). The shape of the pea fermented product is not particularly limited. The pea fermented product may be in any shape, such as a powder, flakes, paste, liquid, etc. That is, the culture may be processed into a desired shape. That is, the method for producing the fermented pea product may include a step of processing the fermented pea product into a desired shape. For example, the culture may be dried and powdered to be used as the fermented pea product. The method for producing the fermented pea product may include, for example, a step of drying and powdering the fermented pea product. Examples of drying methods include freeze drying, spray drying, and drum drying. The fermented pea product may be blended with additives such as excipients.

<1-2-1-2> Pea protein "Pea protein" means a protein derived from pea. "Pea protein" is not limited to full-length pea protein, and may also include fragments thereof (i.e., partial proteins). Fragments of full-length pea protein include hydrolysates of full-length pea protein. That is, the pea protein may, for example, be hydrolyzed or not. In one embodiment, the pea protein may not be hydrolyzed. As the pea protein, one type of protein may be used, or two or more types of proteins may be used in combination.

The type of pea from which the pea protein is derived is not particularly limited. The pea from which the pea protein is derived may be selected, for example, from one that contains a pea protein having a desired function (e.g., growth-improving function). The pea is as described above. The pea protein may be derived from one type of pea, or from two or more types of pea. That is, the pea protein may be a protein derived from one type of pea, or a combination of proteins derived from two or more types of pea.

As the pea protein, a commercially available product may be used, or one obtained by appropriate production may be used. There is no particular limitation on the method for producing the pea protein. The pea protein may be produced, for example, by extraction from peas. The pea protein may be purified to a desired degree, or may not be purified. That is, the pea protein may be a purified product, or a material containing pea protein may be used. An example of a material containing pea protein is a crude extract of pea protein (i.e., a protein crudely extracted from peas). An example of a material containing pea protein is crushed peas (e.g., pea powder). Crushed peas (e.g., pea powder) can be produced by crushing peas. Peas may be crushed, for example, after separation from the pods, or may be crushed without separation from the pods. The pea protein content in the pea protein containing material may be, for example, at least 1% (w/w), at least 5% (w/w), at least 10% (w/w), at least 30% (w/w), at least 50% (w/w), at least 70% (w/w), at least 90% (w/w), or at least 95% (w/w).

In addition, when a material containing pea protein is used, the amount of pea protein (e.g., content (concentration) or amount used) is calculated based on the amount of pea protein itself in the material. The content of pea protein in a target substance (e.g., material or composition) can be measured by a known protein quantification method such as the Kjeldahl method.

<1-2-2> Yeast extract The term "yeast extract" refers to an extract of yeast. As the yeast extract, one type of yeast extract may be used, or two or more types of yeast extracts may be used in combination.

The type of yeast for the yeast extract is not particularly limited. As the yeast for the yeast extract, for example, one that can give a yeast extract having the desired function (for example, a growth-improving function) may be selected. As the yeast for the yeast extract, the yeast exemplified in the method for producing a pea fermented product may be mentioned. As the yeast for the yeast extract, in particular, Saccharomyces yeast such as Saccharomyces cerevisiae, Schizosaccharomyces yeast such as Schizosaccharomyces pombe, and Candida yeast such as Candida utilis may be mentioned. As the yeast for the yeast extract, more particularly, Saccharomyces yeast and Candida yeast may be mentioned. As the yeast for the yeast extract, one type of yeast may be used, or two or more types of yeast may be used in combination.

As the yeast extract, a commercially available product may be used, or one obtained by appropriate production may be used. There are no particular limitations on the method for producing the yeast extract. For example, the yeast extract can be produced from yeast cells by a known method. Methods for preparing yeast extract include autolysis, enzymatic decomposition, acid decomposition, alkaline decomposition, physical crushing, and freezing and thawing.

The form of the yeast extract is not particularly limited. The yeast extract may be in any form, such as powder, flakes, paste, liquid, etc.

<2> Composition of the Present Invention The composition of the present invention is a composition containing an active ingredient (i.e., lecithin).

The composition of the present invention can be used, for example, for culturing animal cells. That is, the composition of the present invention may be a composition for culturing animal cells. The composition of the present invention can be used, for example, for culturing animal cells in the manner described in the method of the present invention described below.

The composition of the present invention (specifically, a composition for animal cell culture) may be, for example, a culture medium. Examples of culture media include basal medium, feed medium, and perfusion medium. "Basal medium" may mean the medium at the start of culture. Basal medium is also called "initial medium." "Fed-batch medium" may mean the medium supplied to the culture system after the start of culture in fed-batch culture. "Perfusion medium" may mean the medium supplied to the culture system after the start of culture in continuous culture (this is not limited to perfusion culture).

The composition of the present invention (specifically, a composition for animal cell culture) may be, for example, a medium additive. "Medium additive" may mean a composition that is added to a medium before use. Media to which the medium additive is added include basal medium, fed-batch medium, and perfusion medium.

The use of the composition of the present invention may improve the growth of animal cells, i.e., an effect of improving the growth of animal cells (growth-improving effect) may be obtained. For example, a growth-improving effect may be obtained by culturing animal cells in a medium containing the composition of the present invention, which is a medium additive. Also, a growth-improving effect may be obtained by culturing animal cells in a medium containing the composition of the present invention, which is a medium additive. In other words, the composition of the present invention may have a function of improving the growth of animal cells (growth-improving function). Thus, the composition of the present invention may be used to improve the growth of animal cells. That is, the composition of the present invention may be, for example, a composition for improving the growth of animal cells.

In one embodiment, a product (e.g., cultured meat or a target substance) may be produced by culturing animal cells. When a product is produced by culturing animal cells, production of the product may be improved by using the composition of the present invention. For example, production of the product may be improved by improving the growth of the animal cells by using the composition of the present invention. That is, one embodiment of the composition of the present invention (specifically, a composition for culturing animal cells) may be a composition for improving production of a product.

The composition of the present invention may consist of an active ingredient, or may contain ingredients other than the active ingredient. Ingredients other than the active ingredient are also referred to as "additional ingredients." In other words, the active ingredient may be used as is or in combination with an additional ingredient in the composition of the present invention. As the additional ingredient, one type of ingredient may be used, or two or more types of ingredients may be used in combination.

The additional components are not particularly limited as long as they can achieve the object of the present invention (for example, a growth-improving effect can be obtained). The additional components can be appropriately selected depending on various conditions, such as the type of animal cells and the manner of use of the composition of the present invention. Examples of the additional components include medium components. Medium components will be described later. For example, at least when the composition of the present invention is a medium, the composition of the present invention may contain medium components. Specific examples of the additional components include pea-derived materials and yeast extract. That is, the composition of the present invention may contain, for example, pea-derived materials and/or yeast extract. The composition of the present invention may contain, for example, particularly, at least pea-derived materials.

The composition of the present invention may be formulated as appropriate, for example. In the formulation, additives may be used as appropriate. In other words, the additional components include additives used in the formulation. Examples of additives include excipients, binders, disintegrants, lubricants, stabilizers, flavorings, diluents, and surfactants. The additives can be selected as appropriate depending on various conditions, such as the shape of the composition of the present invention.

The shape of the composition of the present invention is not particularly limited. The composition of the present invention may be in any shape, such as a powder, flakes, tablets, paste, liquid, etc.

The content and content ratio of each component (i.e., active ingredient and optional additional ingredient) in the composition of the present invention are not particularly limited as long as the object of the present invention can be achieved (e.g., a growth-improving effect can be obtained). The content and content ratio of each component in the composition of the present invention can be appropriately set depending on various conditions such as the type of animal cells and the mode of use of the composition of the present invention.

The content of the active ingredient in the composition of the present invention is greater than 0% (w/w) and less than 100% (w/w). The content of the active ingredient in the composition of the present invention may be, for example, 0.1 μg/g or more, 0.2 μg/g or more, 0.5 μg/g or more, 1 μg/g or more, 2 μg/g or more, 5 μg/g or more, 10 μg/g or more, 20 μg/g or more, 50 μg/g or more, 100 μg/g or more, 1 mg/g or more, 10 mg/g or more, or 100 mg/g or more. , 1000 mg/g or less, 100 mg/g or less, 10 mg/g or less, 1 mg/g or less, 100 μg/g or less, 50 μg/g or less, 20 μg/g or less, 10 μg/g or less, 5 μg/g or less, 2 μg/g or less, 1 μg/g or less, 0.5 μg/g or less, or 0.2 μg/g or less, or any compatible combination thereof. The content of the active ingredient in the composition of the present invention may be, specifically, for example, 0.1 μg/g to 0.2 μg/g, 0.2 μg/g to 0.5 μg/g, 0.5 μg/g to 1 μg/g, 1 μg/g to 2 μg/g, 2 μg/g to 5 μg/g, 5 μg/g to 10 μg/g, 10 μg/g to 20 μg/g, 20 μg/g to 50 μg/g, 50 μg/g to 100 μg/g, 100 μg/g to 1 mg/g, 1 mg/g to 10 mg/g, 10 mg/g to 100 mg/g, or 100 mg/g to 1000 mg/g. Specifically, the content of the active ingredient in the composition of the present invention may be, for example, 0.1 μg/g to 1000 mg/g, 0.2 μg/g to 1000 mg/g, 0.5 μg/g to 1000 mg/g, or 1 μg/g to 1000 mg/g.

The content of the additional component in the composition of the present invention is less than 100% (w/w).

When the composition of the present invention contains a pea fermentate, the content of the pea fermentate in the composition of the present invention may be, for example, 0.1 mg/g or more, 0.2 mg/g or more, 0.5 mg/g or more, 1 mg/g or more, 2 mg/g or more, 5 mg/g or more, 10 mg/g or more, 20 mg/g or more, 50 mg/g or more, 100 mg/g or more, 200 mg/g or more, 500 mg/g or more, 1000 mg/g or more, 2000 mg/g or more, 5000 mg/g or more, 10000 mg/g or more, 20000 mg/g or more, or 50000 The concentration may be 100,000 mg/g or more, 50,000 mg/g or less, 20,000 mg/g or less, 10,000 mg/g or less, 5,000 mg/g or less, 2000 mg/g or less, 1000 mg/g or less, 500 mg/g or less, 200 mg/g or less, 100 mg/g or less, 50 mg/g or less, 20 mg/g or less, 10 mg/g or less, 5 mg/g or less, 2 mg/g or less, 1 mg/g or less, 0.5 mg/g or less, or 0.2 mg/g or less, or any combination thereof that is not contradictory. The content of the pea fermentate in the composition of the present invention may specifically be, for example, 0.1-0.2 mg/g, 0.2-0.5 mg/g, 0.5-1 mg/g, 1-2 mg/g, 2-5 mg/g, 5-10 mg/g, 10-20 mg/g, 20-50 mg/g, 50-100 mg/g, 100-200 mg/g, 200-500 mg/g, 500-1000 mg/g, 1000-2000 mg/g, 2000-5000 mg/g, 5000-10000 mg/g, 10000-20000 mg/g, 20000-50000 mg/g or 50000-100000 mg/g. The content of pea fermented product in the composition of the present invention may specifically be, for example, 0.1 to 100000 mg/g, 0.2 to 20000 mg/g, 0.5 to 5000 mg/g, or 1 to 1000 mg/g. "Content of pea fermented product" means, unless otherwise specified, the content of the pea fermented product converted into the content of the original culture, the content of the pea fermented product converted into the content of the original culture supernatant, or the content of the pea fermented product provided and distributed as a product. That is, for example, "the content of pea fermented product is 0.1 mg/g or more" means, unless otherwise specified, that at least one of the content of the pea fermented product converted into the content of the original culture, the content of the pea fermented product converted into the content of the original culture supernatant, and the content of the pea fermented product provided and distributed as a product is 0.1 mg/g or more. The term "original culture" refers to a culture in which no concentration change such as concentration or dilution has occurred after the culture, and specifically refers to the culture at the end of the culture. The original culture is also called "original fermentation product". The term "original culture supernatant" refers to a culture supernatant in which no concentration change such as concentration or dilution has occurred after the culture other than solid-liquid separation, and specifically refers to the supernatant obtained by solid-liquid separation of the culture at the end of the culture. An example of a fermented pea product that is provided and distributed as a product is commercially available pea soy sauce. Note that a content of more than 100% (w/w) (i.e., 1000 mg/g) means that the culture is concentrated and contained in the composition of the present invention. That is, for example, a content of 2000 mg/g means that the culture is concentrated twice as much after the culture and contained in the composition of the present invention.

When the composition of the present invention contains pea protein, the content of pea protein in the composition of the present invention may be, for example, 0.05 mg/g or more, 0.1 mg/g or more, 0.2 mg/g or more, 0.5 mg/g or more, 1 mg/g or more, 2 mg/g or more, 5 mg/g or more, 10 mg/g or more, 20 mg/g or more, 50 mg/g or more, 100 mg/g or more, 200 mg/g or more, 500 mg/g or more, 700 mg/g or more, or may be greater than or equal to 900 mg/g, or less than 1000 mg/g, less than or equal to 900 mg/g, less than or equal to 700 mg/g, less than or equal to 500 mg/g, less than or equal to 200 mg/g, less than or equal to 100 mg/g, less than or equal to 50 mg/g, less than or equal to 20 mg/g, less than or equal to 10 mg/g, less than or equal to 5 mg/g, less than or equal to 2 mg/g, less than or equal to 1 mg/g, less than or equal to 0.5 mg/g, less than or equal to 0.2 mg/g, or less than or equal to 0.1 mg/g, or any combination thereof that is not contradictory. The pea protein content in the composition of the present invention may specifically be, for example, 0.05-0.1 mg/g, 0.1-0.2 mg/g, 0.2-0.5 mg/g, 0.5-1 mg/g, 1-2 mg/g, 2-5 mg/g, 5-10 mg/g, 10-20 mg/g, 20-50 mg/g, 50-100 mg/g, 100-200 mg/g, 200-500 mg/g, 500-700 mg/g, 700-900 mg/g or greater than 900 mg/g but less than 1000 mg/g. Specifically, the pea protein content in the composition of the present invention may be, for example, 0.05 mg/g or more and less than 1000 mg/g, 0.1 mg/g or more and less than 1000 mg/g, 0.2 mg/g or more and less than 1000 mg/g, or 0.5 mg/g or more and less than 1000 mg/g.

When the composition of the present invention contains yeast extract, the content of yeast extract in the composition of the present invention may be, for example, 0.01 mg/g or more, 0.02 mg/g or more, 0.05 mg/g or more, 0.1 mg/g or more, 0.2 mg/g or more, 0.5 mg/g or more, 1 mg/g or more, 2 mg/g or more, 5 mg/g or more, 10 mg/g or more, 20 mg/g or more, 50 mg/g or more, 100 mg/g or more, 200 mg/g or more, 500 mg/g or more, 700 mg/g or more, or 900 mg/g or more. It may be greater than or equal to 1000 mg/g, less than 900 mg/g, less than or equal to 700 mg/g, less than or equal to 500 mg/g, less than or equal to 200 mg/g, less than or equal to 100 mg/g, less than or equal to 50 mg/g, less than or equal to 20 mg/g, less than or equal to 10 mg/g, less than or equal to 5 mg/g, less than or equal to 2 mg/g, less than or equal to 1 mg/g, less than or equal to 0.5 mg/g, less than or equal to 0.2 mg/g, less than or equal to 0.1 mg/g, less than or equal to 0.05 mg/g, or less than or equal to 0.02 mg/g, or any combination thereof that is not contradictory. The content of yeast extract in the composition of the present invention may be, specifically, for example, 0.01-0.02 mg/g, 0.02-0.05 mg/g, 0.05-0.1 mg/g, 0.1-0.2 mg/g, 0.2-0.5 mg/g, 0.5-1 mg/g, 1-2 mg/g, 2-5 mg/g, 5-10 mg/g, 10-20 mg/g, 20-50 mg/g, 50-100 mg/g, 100-200 mg/g, 200-500 mg/g, 500-700 mg/g, 700-900 mg/g, or greater than 900 mg/g and less than 1000 mg/g. Specifically, the content of yeast extract in the composition of the present invention may be, for example, 0.01 mg/g or more and less than 1000 mg/g, 0.02 mg/g or more and less than 1000 mg/g, 0.05 mg/g or more and less than 1000 mg/g, or 0.1 mg/g or more and less than 1000 mg/g. "Yeast extract content" means the content of yeast extract calculated based on the dry weight of yeast extract.

In one embodiment, the composition of the present invention may be substantially free of serum. "The composition of the present invention is substantially free of serum" may mean that the serum content in the composition of the present invention is 1% (w/w) or less, 0.1% (w/w) or less, 0.01% (w/w) or less, or 0.001% (w/w) or less, and may also include the case where the serum content in the composition of the present invention is 0 (zero) (i.e., the composition of the present invention does not contain serum).

In one embodiment, the composition of the present invention may be substantially free of animal-derived albumin. "The composition of the present invention is substantially free of animal-derived albumin" may mean that the content of animal-derived albumin in the composition of the present invention is 1% (w/w) or less, 0.1% (w/w) or less, 0.01% (w/w) or less, or 0.001% (w/w) or less, and may also include the case where the content of animal-derived albumin in the composition of the present invention is 0 (zero) (i.e., the composition of the present invention does not contain animal-derived albumin).

The content of each component (i.e., active ingredient and optional additional ingredient) in the composition of the present invention can be set, for example, so as to obtain the concentration of each component in the medium in the method of the present invention described below.

When the composition of the present invention contains two or more kinds of ingredients, those ingredients may be mixed together and contained in the composition of the present invention, or may be contained separately in the composition of the present invention, or separately in any combination. For example, the composition of the present invention may be provided as a set consisting of a package of an active ingredient and a package of an additional ingredient. In such a case, the ingredients contained in the set can be used together as appropriate when used.

<3> The method of the present invention The method of the present invention is a method for culturing animal cells, which comprises a step of culturing animal cells in the presence of an active ingredient (i.e., lecithin). This step is also referred to as a "step of culturing animal cells."

By using the active ingredient, specifically by culturing the animal cells in the presence of the active ingredient, the growth of the animal cells may be improved, i.e., an effect of improving the growth of the animal cells (growth-improving effect) may be obtained. That is, one aspect of the method of the present invention (specifically, the method of culturing animal cells) may be, for example, a method of improving the growth of animal cells.

The purpose of culturing animal cells is not particularly limited.

In one aspect, a product (e.g., cultured meat or a target substance) may be produced by culturing animal cells. That is, if animal cells are capable of forming cultured meat by culturing, cultured meat can be produced by culturing the cells. Cultured meat may be mainly composed of muscle tissue. Thus, "animal cells are capable of forming cultured meat by culturing" may mean, for example, that animal cells are capable of differentiating to form muscle tissue by culturing, and specifically may mean that animal cells are capable of differentiating into myotube cells by culturing to form muscle tissue. Also, if animal cells have the ability to produce a target substance, the target substance can be produced by culturing the cells. That is, one aspect of the method of the present invention (specifically, the method of culturing animal cells) may be a method of producing a product, which includes a step of culturing animal cells in the presence of an active ingredient. Also, the step of culturing animal cells may specifically be a step of culturing animal cells in the presence of an active ingredient to produce a product. In the method of producing cultured meat, cultured animal cells may form cultured meat. In the method of producing a target substance, cultured animal cells may produce the target substance. When a product is produced by culturing animal cells, the production of the product may be improved by using an active ingredient. For example, the production of the product may be improved by improving the growth of the animal cells through the use of an active ingredient. In other words, one aspect of the method of the present invention (specifically, the method for culturing animal cells) may be a method for improving the production of a product.

"Animal cells" refers to cells of an animal. The animal cells are not particularly limited. The animal cells can be appropriately selected depending on various conditions, such as the purpose of culturing the animal cells. For example, when producing cultured meat by culturing animal cells, the animal cells are not particularly limited as long as they can form cultured meat by culturing. "Animal" may refer to organisms classified in the Animalia kingdom. Examples of animals include vertebrates and aquatic organisms. Examples of vertebrates include mammals, birds, reptiles, amphibians, and fish. Examples of vertebrates in particular include mammals, birds, and fish. Examples of vertebrates in particular include mammals. Examples of mammals include primates such as humans, monkeys, and chimpanzees; rodents such as hamsters, mice, rats, and guinea pigs; other terrestrial mammals such as cows, pigs, sheep, goats, rabbits, horses, deer, water buffalo, reindeer, donkeys, camels, dogs, and cats; and aquatic mammals such as whales, dolphins, reindeers, and sea lions. Birds include chickens, turkeys, ducks, geese, guinea fowl, quails, and ostriches. Fish include eels, tuna, grouper, sea bream, salmon, cod, and pufferfish. Aquatic organisms include aquatic mammals and fish, as well as crustaceans such as shrimp and crabs, shellfish such as scallops and oysters, and other aquatic organisms such as squid and octopus. Aquatic organisms in particular include fish and crustaceans. Animals suitable for the production of cultured meat include animals for meat. Animals for meat include those animals whose meat can be eaten among the above-mentioned examples. Animals for meat (particularly mammals) in particular include cows, pigs, sheep, goats, and rabbits. Animals for meat (particularly mammals) in particular include cows and pigs. Animals for meat (particularly mammals) in particular include cows. Animals for meat (particularly mammals) in particular include cows. Examples of meat-producing animals (particularly birds) include chickens, turkeys, ducks, geese, guinea fowls, quails, and ostriches. Examples of meat-producing animals (particularly birds) include chickens. Examples of meat-producing animals (particularly aquatic organisms) include fish and crustaceans exemplified above. Examples of meat-producing animals (particularly aquatic organisms) include eels, tuna, and shrimp. The tissue or cell from which the animal cell is derived is not particularly limited. Examples of tissue or cell from which the animal cell is derived include ovaries, kidneys, adrenal glands, tongue epithelium, olfactory epithelium, pineal gland, thyroid gland, melanocytes, skin, spleen, liver, lungs, pancreas, uterus, stomach, colon, small intestine, large intestine, bladder, prostate, testes, thymus, muscles, connective tissues, bones, cartilage, vascular tissues, blood (including umbilical cord blood), bone marrow, heart, eyes, brain, and nervous tissues. The animal cells may or may not be differentiated. Specific examples of animal cells include germ cells, somatic cells, stem cells, and progenitor cells. Germ cells include sperm and eggs. Somatic cells include myoblasts, fibroblasts, bone marrow cells, B lymphocytes, T lymphocytes, neutrophils, red blood cells, platelets, macrophages, monocytes, bone cells, pericytes, dendritic cells, adipocytes, mesenchymal cells, epithelial cells, epidermal cells (e.g., keratinocytes, keratinocytes, etc.), endothelial cells, vascular endothelial cells, hepatic parenchymal cells, chondrocytes, cumulus cells, nerve cells, glial cells, oligodendrocytes, microglia, astrocytes, cardiac cells, esophageal cells, muscle cells (e.g., smooth muscle cells, skeletal muscle cells), pancreatic beta cells, melanocytes, and mononuclear cells. Stem cells include adult stem cells such as hematopoietic stem cells, satellite cells, neural stem cells, mesenchymal stem cells, mammary stem cells, olfactory mucosa stem cells, neural crest stem cells, hepatic stem cells, pancreatic stem cells, muscle stem cells, germline stem cells, intestinal stem cells, and hair follicle stem cells; pluripotent stem cells such as embryonic stem cells (ES cells), embryonic tumor cells, embryonic germ stem cells, and induced pluripotent stem cells (iPS cells); and cancer stem cells. Progenitor cells include satellite cells, pancreatic progenitor cells, vascular progenitor cells, vascular endothelial progenitor cells, and hematopoietic progenitor cells (e.g., CD34-positive cells derived from umbilical cord blood). Animal cells suitable for producing cultured meat include stem cells such as mesenchymal stem cells, embryonic stem cells (ES cells), and induced pluripotent stem cells (iPS cells), as well as myoblasts.

The animal cells are cultured in the presence of an active ingredient. "The animal cells are cultured in the presence of an active ingredient" may mean, for example, that the animal cells are cultured in a medium containing the active ingredient. "The animal cells are cultured in the presence of an active ingredient" may mean, for example, that the active ingredient is supplied to the culture system when the animal cells are cultured.

The active ingredient may be used, for example, in the form of the composition of the present invention for culturing animal cells. The composition of the present invention may be used, for example, as a culture medium for culturing animal cells. That is, for example, when the composition of the present invention is a culture medium, animal cells may be cultured in the composition of the present invention (i.e., the culture medium). That is, "culturing animal cells in a culture medium containing an active ingredient" may also include culturing animal cells in the composition of the present invention, which is a culture medium. Also, the composition of the present invention may be used, for example, as a culture medium additive for culturing animal cells. That is, for example, when the composition of the present invention is a culture medium additive, the composition of the present invention (i.e., the culture medium additive) may be added to the culture medium, and animal cells may be cultured in the culture medium to which the composition of the present invention has been added. That is, "culturing animal cells in a culture medium containing an active ingredient" may also include culturing animal cells in a culture medium to which the composition of the present invention, which is a culture medium additive, has been added. Also, for example, the composition of the present invention or a culture medium to which the composition has been added may be supplied to a culture system when culturing animal cells. That is, "supplying an active ingredient to a culture system when culturing animal cells" may also include supplying the composition of the present invention or a culture medium to which the composition has been added to a culture system when culturing animal cells.

The medium composition and culture conditions are not particularly limited as long as the purpose of culturing the animal cells can be achieved, except that the animal cells are cultured in the presence of an active ingredient. The medium composition and culture conditions can be set appropriately depending on various conditions, such as the type of animal cells and the purpose of culturing the animal cells. For example, when producing cultured meat by culturing animal cells, the medium composition and culture conditions are not particularly limited as long as cultured meat can be formed by culturing the animal cells. Except that the animal cells are cultured in the presence of an active ingredient, the medium composition and culture conditions can be used, for example, as a normal medium and normal conditions used for culturing animal cells, either as is or with appropriate modifications. When producing cultured meat by culturing animal cells, the animal cells are cultured in the presence of an active ingredient, either as is or with appropriate modifications, as a normal medium and normal conditions used for forming muscle tissue by differentiation of animal cells (e.g., producing cultured meat).

Cultivation can be carried out, for example, using a liquid medium. Cultivation can be carried out by batch culture, fed-batch culture, continuous culture, or a combination of these. Continuous culture includes perfusion culture and chemostat culture. The medium at the start of the culture is also called the "initial medium" or "basal medium". The medium supplied to the culture system (e.g., the initial medium) in fed-batch culture is also called the "feed medium". The medium supplied to the culture system (e.g., the initial medium) in continuous culture (not limited to perfusion culture) is also called the "perfusion medium". Supplying the fed-batch medium or perfusion medium to the culture system in fed-batch culture or continuous culture is also simply called "medium supply". Medium supply may be carried out throughout the entire culture period, or only during a portion of the culture period. In addition, the medium supply may be performed continuously or intermittently. During culture (particularly continuous culture such as perfusion culture), the culture medium may be withdrawn. The culture medium may be withdrawn throughout the entire culture period, or only during a portion of the culture period. The culture medium may be withdrawn continuously or intermittently. The culture medium withdrawal and the medium supply may be performed simultaneously, or not. The culture vessel may be coated with a cell adhesion molecule such as fibronectin. The culture may be performed three-dimensionally, for example, using a scaffold material. When producing cultured meat by culturing animal cells, the culture may be performed three-dimensionally, for example, using a scaffold material that matches the shape of the cultured meat to be formed.

The media used for culture can be selected independently for each of the basal medium, the feed medium, and the perfusion medium, for example.

The medium used for the culture may be a commercially available medium or a medium prepared as appropriate.

The medium used for culture includes media containing components essential for culturing animal cells (e.g., carbon source, nitrogen source, inorganic salts, etc.).

Specific media used for culture include Dulbecco's Modified Eagle's Medium (DMEM), Ham's Nutrient Mixture F12, DMEM/F12 medium, McCoy's 5A medium, Minimum Essential Medium (MEM), Eagle's Minimum Essential Medium (EMEM), and alpha modified Eagle's minimum essential medium (EMEM). These include alpha Modified Eagle's Minimum Essential Medium (αMEM), Roswell Park Memorial Institute (RPMI) 1640 medium, Iscove's Modified Dulbecco's Medium (IMDM), MCDB131 medium, William's Medium E, and Fischer's Medium.

Furthermore, examples of media used for culture (for example, media used particularly for culturing stem cells (particularly pluripotent stem cells)) include STEMPRO (registered trademark) hESC SFM medium (Life Technologies), mTeSR1 medium (STEMCELL Technologies), TeSR2 medium (STEMCELL Technologies), TeSR-E8 medium (STEMCELL Technologies), Essential 8 medium (Life Technologies), HEScGRO (trademark) Serum-Free Medium for hES cells (Millipore), PluriSTEM (trademark) Human ES/iPS Medium (EMD Millipore), NutriStem ... Examples include ESC XF medium (Biological Industries Israel Beit-Haemek), NutriStem (trademark) XF/FF Culture Medium (Stemgent), AF NutriStem (registered trademark) hESC XF medium (Biological Industries Israel Beit-Haemek), S-medium (DS Pharma Biomedical Co., Ltd.), StemFit (registered trademark) AK03N medium (Ajinomoto Co., Inc.), hESF9 medium, hESF-FX medium, CDM medium, DEF-CS 500 Xeno-Free 3D Spheroid Culture Medium (Cellartis), and StemFlex medium (Thermo Fisher Scientific).

Other commercially available media include media for animal cell culture such as D-MEM (Dulbecco's Modified Eagle Medium), CELLiST Basal Media BASAL3, BASAL4P, BASAL10 (Ajinomoto Co., Inc.), Opti-MEM (Thermo Fisher Scientific), RPMI 1640 (Thermo Fisher Scientific), CD293 (Thermo Fisher Scientific), CHO-S-SFMII (Thermo Fisher Scientific), CHO-SF (Sigma-Aldrich), EX-CELL CD CHO (Sigma-Aldrich), EX-CELLTM302 (Sigma-Aldrich), IS CHO-CD (Irvine Scientific), and IS CHO-CDXP (Irvine Scientific).

The media exemplified above may be used for culture by adding active ingredients, for example.

The medium used for the culture may be, for example, the composition of the present invention (specifically, the composition of the present invention that is a culture medium). That is, when the composition of the present invention is a culture medium, the composition of the present invention may be used for the culture as is, or may be appropriately prepared as a liquid medium of a desired composition. For example, the composition of the present invention may be diluted with an aqueous medium such as water or an aqueous buffer solution to prepare a liquid medium and used for the culture.

The medium used for the culture may be, for example, a medium to which the composition of the present invention (specifically, the composition of the present invention that is a medium additive) has been added. The medium to which the composition of the present invention is added may be a commercially available medium or an appropriately prepared medium.

The medium may contain various medium components. Examples of medium components include carbon sources, amino acid sources, peptides, proteins, vitamins, fatty acids, lipids, inorganic components, pH buffers, growth factors, cytokines, hormones, cell adhesion factors, extracellular matrix components, serum, pea-derived materials, yeast extract, antibiotics, and gene expression inducers. Any of these medium components may be essential or effective for the survival or proliferation of animal cells, for example. Any of these medium components may be pre-contained in the medium, for example, as exemplified above, or may be added to the medium, for example, as exemplified above.

Carbon sources include sugars such as glucose, fructose, sucrose, and maltose.

Amino acid sources include amino acids. In addition, both peptides and proteins can be examples of amino acid sources. Amino acids include glycine, alanine, valine, leucine, isoleucine, cysteine, methionine, phenylalanine, tyrosine, tryptophan, histidine, lysine, arginine, serine, threonine, aspartic acid, glutamic acid, asparagine, glutamine, proline, and ornithine. Amino acids may be, for example, in the L-form.

Peptides include dipeptides and tripeptides. Specific examples of peptides include glycylglycylglycine and soybean peptide. The descriptions of amino acids can also be applied mutatis mutandis to the amino acids that make up peptides.

Proteins include albumin and transferrin.

Vitamins include vitamin A, vitamin B1, vitamin B2, vitamin B3, vitamin B5, vitamin B6, vitamin B7, vitamin B9, vitamin B12, vitamin C, vitamin D, vitamin E, and vitamin K, as well as their precursors.

Fatty acids include oleic acid, arachidonic acid, and linoleic acid.

An example of lipids is cholesterol.

Inorganic components include sodium, potassium, calcium, magnesium, phosphorus, and various trace elements (e.g., Co, Cu, F, Fe, Mn, Mo, Ni, Se, Si, Ni, Bi, V, and Zn). Specific examples of inorganic components include inorganic salts such as sodium chloride, potassium chloride, calcium chloride, magnesium sulfate, and sodium dihydrogen phosphate.

pH buffers include sodium bicarbonate, phosphate, N,N-bis(2-hydroxyethyl)-2-aminoethanesulfonic acid (BES), 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), and N-[tris(hydroxymethyl)methyl]glycine (Tricine).

Growth factors include fibroblast growth factor (FGF), hepatocyte growth factor (HGF), epidermal growth factor (EGF), transforming growth factor (TGF)-α, transforming growth factor (TGF)-β, vascular endothelial growth factor (VEGF), activin A, and insulin-like growth factor-1 (IGF-1). FGF includes basic fibroblast growth factor (bFGF). Growth factors include, in particular, bFGF. That is, at least bFGF may be used as a medium component. That is, the medium may contain at least bFGF. As bFGF, bovine basic fibroblast growth factor (bbFGF) may be used. "Bovine basic fibroblast growth factor (bbFGF)" may mean bovine-derived bFGF. "Bovine" with respect to bbFGF may mean organisms of the genus Bos. An example of an organism of the genus Bos is Bos taurus. bbFGF is not limited to bFGF found in organisms of the genus Bos, and may be a modified form thereof.

Cytokines include interleukins.

Hormones include dexamethasone, hydrocortisone, estradiol, progesterone, glucagon, and insulin.

Cell adhesion factors or extracellular matrix components include type I collagen, type II collagen, fibronectin, laminin, poly-L-lysine, and poly-D-lysine.

Antibiotics include amphotericin B, kanamycin, gentamicin, streptomycin, and penicillin.

In one embodiment, the medium may be substantially free of serum. The medium may be substantially free of serum, for example, throughout the entire culture period. "The medium is substantially free of serum" may mean that the serum content in the medium is 1% (w/w) or less, 0.1% (w/w) or less, 0.01% (w/w) or less, or 0.001% (w/w) or less, and may also include the case where the serum content in the medium is 0 (zero) (i.e., the medium does not contain serum).

In one embodiment, the medium may be substantially free of animal-derived albumin. Examples of animals from which albumin is derived include animals exemplified for animal cells. The medium may be substantially free of animal-derived albumin, for example, throughout the entire culture period. "The medium is substantially free of animal-derived albumin" may mean that the content of animal-derived albumin in the medium is 1% (w/w) or less, 0.1% (w/w) or less, 0.01% (w/w) or less, or 0.001% (w/w) or less, and may also include the case where the content of animal-derived albumin in the medium is 0 (zero) (i.e., the medium does not contain animal-derived albumin).

All of the various components, such as the active ingredient, may be contained in the initial medium, the feed medium, the perfusion medium, or a combination thereof. That is, during the culture process, all of the various components, such as the active ingredient, may be supplied to the medium alone or in any combination. All of these components may be supplied once or multiple times, or may be supplied continuously. The compositions (e.g., the types and/or concentrations of the components contained) of the initial medium, the feed medium, and the perfusion medium may be the same or different. That is, the types of components contained in the initial medium may be the same or different from the types of components contained in the feed medium or the perfusion medium. In addition, the concentrations of each component contained in the initial medium may be the same or different from the concentrations of each component contained in the feed medium or the perfusion medium. For example, when the feed medium is used for perfusion culture, the compositions of the initial medium and the feed medium may be the same. In addition, two or more feed media or perfusion media with different compositions (e.g., the types and/or concentrations of the components contained) may be used. For example, when the feed medium or perfusion medium is supplied intermittently multiple times, the composition of the feed medium or perfusion medium may or may not be the same each time. In addition, various components such as active ingredients may be supplied to the medium in a form that is not contained in the feed medium or perfusion medium, such as a powder.

The amount of animal cells seeded at the start of culture may be, for example, in terms of the number of viable cells, 1 x ¹⁰² cells/mL or more, 1 x ¹⁰³ cells/mL or more, 1 x ¹⁰⁴ cells/mL or more, 1 x ¹⁰⁵ cells/mL or more, 1 x ¹⁰⁶ cells/mL or more, or 1 x ¹⁰⁷ cells/mL or more, or 1 x ¹⁰⁸ cells/mL or less, 1 x ¹⁰⁷ cells/mL or less, 1 x ¹⁰⁶ cells/mL or less, 1 x ¹⁰⁵ cells/mL or less, 1 x ¹⁰⁴ cells/mL or less, or 1 x ¹⁰³ cells/mL or less, or any compatible combination thereof. The seeding amount of animal cells at the start of culture may be, for example, 1×10 ² to 1×10 ³ cells/mL, 1×10 ³ to 1×10 ⁴ cells/mL, 1×10 ⁴ to 1×10 ⁵ cells/mL, 1×10 ⁵ to 1×10 ⁶ cells/mL, 1×10 ⁶ to 1×10 ⁷ cells/mL, or 1×10 ⁷ to 1×10 ⁸ cells/mL, in terms of the number of live cells. The seeding amount of animal cells at the start of culture may be, for example, 1×10 ² to 1×10 ⁸ cells/mL, 1×10 ³ to 1×10 ⁷ cells/mL, or 1×10 ³ to 1×10 ⁶ cells/mL, in terms of the number of live cells. The number of live cells can be measured, for example, using a live/dead cell autoanalyzer Vi-CELL ^TM XR (Beckman Coulter).

The culture may be carried out, for example, under a _{CO2 -} containing atmosphere such as 5-15% CO2. The pH of the medium may be, for example, near neutral. "Near neutral" may mean, for example, pH 6-8, pH 6.5-7.5, or pH 6.8-7.2. During the culture, the pH of the medium may be adjusted as necessary. The pH of the medium may be adjusted using various alkaline or acidic substances such as ammonia gas, ammonia water, sodium carbonate, sodium bicarbonate, potassium carbonate, potassium bicarbonate, magnesium carbonate, sodium hydroxide, potassium hydroxide, calcium hydroxide, and magnesium hydroxide. The culture temperature may be, for example, 30-38°C. The culture period may be, for example, 0.5 days or more, 1 day or more, 2 days or more, 3 days or more, 4 days or more, 5 days or more, 6 days or more, 7 days or more, 8 days or more, 9 days or more, 10 days or more, 12 days or more, 15 days or more, or 20 days or more, or 60 days or less, 50 days or less, 40 days or less, 30 days or less, 25 days or less, 20 days or less, 15 days or less, 12 days or less, 10 days or less, 9 days or less, 8 days or less, or 7 days or less, or a combination thereof that is not inconsistent. Specifically, the culture period may be, for example, 1 to 60 days, 3 to 25 days, or 5 to 20 days. The culture may be continued, for example, until the product is produced to a desired extent.

The concentration of the active ingredient in the culture medium may be, for example, 0.1 μg/mL or more, 0.2 μg/mL or more, 0.5 μg/mL or more, 1 μg/mL or more, 2 μg/mL or more, 5 μg/mL or more, 7 μg/mL or more, 10 μg/mL or more, 15 μg/mL or more, 20 μg/mL or more, 30 μg/mL or more, or 50 μg/mL or more, or 100 μg/mL or less, 50 μg/mL or less, 30 μg/mL or less, 20 μg/mL or less, 15 μg/mL or less, 10 μg/mL or less, 7 μg/mL or less, 5 μg/mL or less, 2 μg/mL or less, 1 μg/mL or less, 0.5 μg/mL or less, or 0.2 μg/mL or less, or any compatible combination thereof. The concentration of the active ingredient in the medium may be, for example, 0.1-0.2 μg/mL, 0.2-0.5 μg/mL, 0.5-1 μg/mL, 1-2 μg/mL, 2-5 μg/mL, 5-7 μg/mL, 7-10 μg/mL, 10-15 μg/mL, 15-20 μg/mL, 20-30 μg/mL, 30-50 μg/mL, or 50-100 μg/mL. The concentration of the active ingredient in the medium may be, for example, 0.1-100 μg/mL, 0.2-50 μg/mL, 0.5-30 μg/mL, or 1-15 μg/mL.

The culture of the animal cells may be carried out in the presence of pea-derived material and/or yeast extract. The culture of the animal cells may in particular be carried out in the presence of at least pea-derived material. "The culture of the animal cells is carried out in the presence of a certain component (e.g., a pea-derived material or yeast extract)" may mean, for example, that the animal cells are cultured in a medium containing the component. "The culture of the animal cells is carried out in the presence of a certain component (e.g., a pea-derived material or yeast extract)" may mean, for example, that the component is supplied to the culture system when the animal cells are cultured.

When the medium contains pea fermentate, the concentration of the pea fermentate in the medium may, for example, be at least 0.1 mg/mL, at least 0.2 mg/mL, at least 0.5 mg/mL, at least 1 mg/mL, at least 2 mg/mL, at least 5 mg/mL, at least 10 mg/mL, at least 20 mg/mL, or at least 50 mg/mL, or at most 100 mg/mL, at most 50 mg/mL, at most 20 mg/mL, at most 10 mg/mL, at most 5 mg/mL, at most 2 mg/mL, at most 1 mg/mL, at most 0.5 mg/mL, or at most 0.2 mg/mL, or any compatible combination thereof. The concentration of the pea fermentate in the culture medium may be, for example, 0.1-0.2 mg/mL, 0.2-0.5 mg/mL, 0.5-1 mg/mL, 1-2 mg/mL, 2-5 mg/mL, 5-10 mg/mL, 10-20 mg/mL, 20-50 mg/mL or 50-100 mg/mL. The concentration of the pea fermentate in the culture medium may be, for example, 0.1-100 mg/mL, 0.2-50 mg/mL, 0.5-20 mg/mL or 1-10 mg/mL. "Concentration of the pea fermentate" is understood to mean, unless otherwise specified, the concentration of the pea fermentate converted to the concentration of the original culture, the concentration of the pea fermentate converted to the concentration of the original culture supernatant or the concentration of the pea fermentate as provided and distributed as a product. That is, for example, unless otherwise specified, "the concentration of the pea fermented product is 0.1 mg/mL or more" means that at least one of the concentration of the pea fermented product converted to the concentration of the original culture, the concentration of the pea fermented product converted to the concentration of the original culture supernatant, and the concentration of the pea fermented product provided and distributed as a product is 0.1 mg/mL or more. For example, if a culture that has been concentrated twice after cultivation is added to a medium so that the concentration is 0.1 mg/mL, the concentration of the pea fermented product in the medium, converted to the concentration of the original culture, is 0.2 mg/mL.

If the medium contains pea protein, the concentration of pea protein in the medium may be, for example, 0.05 mg/mL or more, 0.1 mg/mL or more, 0.2 mg/mL or more, 0.5 mg/mL or more, 1 mg/mL or more, 2 mg/mL or more, 5 mg/mL or more, 7 mg/mL or more, 10 mg/mL or more, 15 mg/mL or more, 20 mg/mL or more, or 30 mg/mL or more, or 50 mg/mL or less, 30 mg/mL or less, 20 mg/mL or less, 15 mg/mL or less, 10 mg/mL or less, 7 mg/mL or less, 5 mg/mL or less, 2 mg/mL or less, 1 mg/mL or less, 0.5 mg/mL or less, 0.2 mg/mL or less, or 0.1 mg/mL or less, or any compatible combination thereof. The concentration of the pea protein in the medium may be, for example, 0.05-0.05 mg/mL, 0.1-0.1 mg/mL, 0.2-0.2 mg/mL, 0.5-0.5 mg/mL, 1-1 mg/mL, 2-2 mg/mL, 5-5 mg/mL, 7-7 mg/mL, 10-10 mg/mL, 15-15 mg/mL, 20-20 mg/mL, or 30-50 mg/mL. The concentration of the pea protein in the medium may be, for example, 0.05-50 mg/mL, 0.1-30 mg/mL, 0.2-20 mg/mL, or 0.5-15 mg/mL.

If the medium contains yeast extract, the concentration of yeast extract in the medium may be, for example, 0.01 mg/mL or more, 0.02 mg/mL or more, 0.05 mg/mL or more, 0.1 mg/mL or more, 0.2 mg/mL or more, 0.5 mg/mL or more, 1 mg/mL or more, 2 mg/mL or more, or 5 mg/mL or more, or 10 mg/mL or less, 5 mg/mL or less, 2 mg/mL or less, 1 mg/mL or less, 0.5 mg/mL or less, 0.2 mg/mL or less, 0.1 mg/mL or less, 0.05 mg/mL or less, or 0.02 mg/mL or less, or any compatible combination thereof. The concentration of yeast extract in the medium may be, for example, 0.01-0.02 mg/mL, 0.02-0.05 mg/mL, 0.05-0.1 mg/mL, 0.1-0.2 mg/mL, 0.2-0.5 mg/mL, 0.5-1 mg/mL, 1-2 mg/mL, 2-5 mg/mL, or 5-10 mg/mL. The concentration of yeast extract in the medium may be, for example, 0.01-10 mg/mL, 0.02-5 mg/mL, 0.05-2 mg/mL, or 0.1-1 mg/mL. "Yeast extract concentration" means the concentration of yeast extract calculated based on the dry weight of yeast extract.

All of the various components, such as the active ingredient, may be contained in the medium throughout the entire culture period, or may be contained in the medium only during part of the culture period. In other words, "culture is carried out in a medium containing a certain component" means that the component needs to be contained in the medium during at least part of the culture period, and does not require that the component be contained in the medium throughout the entire culture period. All of the various components, such as the active ingredient, may be contained in the medium, for example, at the start of culture, or may be supplied to the medium after the start of culture. All of the various components, such as the active ingredient, may be contained in the medium at the start of culture, and may be further supplied to the medium after the start of culture (for example, after the active ingredient has been consumed).

Each of the various components, such as the active ingredient, may be contained in the medium at the concentration exemplified above for the entire culture period, or may be contained in the medium at the concentration exemplified above for only a part of the culture period. In other words, "culture is carried out in a medium containing a certain component at a certain concentration," "a certain component is contained in the medium at a certain concentration during culture," or "the concentration of a certain component in the medium during culture is a certain concentration" means that the concentration of the component in the medium is within the range of the concentration during at least a part of the culture period, and does not require that the concentration of the component in the medium be within the range of the concentration during the entire culture period. Each of the various components, such as the active ingredient, may be contained in the medium at the concentration exemplified above for example at the start of culture, or may be supplied to the medium after the start of culture so that the concentration is the above example. Each of the various components, such as the active ingredient, may be contained in the medium at the concentration exemplified above for example at the start of culture, and may be further supplied to the medium after the start of culture (e.g., after the component is consumed) so that the concentration is the above example.

The length of the "partial culture period" is not particularly limited as long as the object of the present invention can be achieved (e.g., a growth improvement effect can be obtained). The length of the "partial culture period" can be appropriately set according to various conditions such as the type of animal cells and the length of the culture period. The "partial culture period" may be, for example, 10% or more, 20% or more, 30% or more, 40% or more, 50% or more, 60% or more, 70% or more, 80% or more, 90% or more, 95% or more, 97% or more, or 99% or more of the entire culture period. In addition, the "partial culture period" may be, for example, 10% or more, 20% or more, 30% or more, 40% or more, 50% or more, 60% or more, 70% or more, 80% or more, 90% or more, 95% or more, 97% or more, or 99% or more of the entire culture period after the animal cells have differentiated into myotubes. Furthermore, a "partial period" may be, for example, 0.5 days or more, 1 day or more, 2 days or more, 3 days or more, 4 days or more, 5 days or more, 6 days or more, 7 days or more, 8 days or more, 9 days or more, 10 days or more, 12 days or more, or 15 days or more.

The concentrations of various components such as active ingredients in the medium may be set to the above-mentioned concentrations as average values over a specific period during culture. That is, "culture is performed in a medium containing a certain component at a certain concentration," "a certain component is contained in the medium at a certain concentration during culture," or "the concentration of a certain component in the medium at culture is a certain concentration" may mean that the average value of the concentration of the component in the medium over a specific period during culture is within the range of concentrations. "The average value of the concentration of a certain component in the medium over a specific period during culture" is not particularly limited as long as it is possible to grasp the fluctuation of the concentration of the component over a specific period during culture, but may mean, for example, the average value of the concentration of the component in the medium measured every 60 minutes, every 30 minutes, every 20 minutes, or every 10 minutes over a specific period during culture. "A specific period during culture" may be the entire period of culture or a part of the period of culture. "A part of the period of culture" is as described above.

All of the various components, such as the active ingredient, may be supplied to the medium throughout the entire culture period, or may be supplied to the medium only during a portion of the culture period. The "part of the culture period" is as described above. All of the various components, such as the active ingredient, may be supplied to the medium, for example, continuously, or may be supplied to the medium intermittently. All of the various components, such as the active ingredient, may be supplied to the medium, for example, every day, or every few days.

The concentrations of various components such as active ingredients in the feed medium or perfusion medium may be within the range of the concentrations of the components in the media exemplified above. The concentrations of various components such as active ingredients in the feed medium or perfusion medium may be, for example, 1x or more, 1.1x or more, 1.3x or more, 1.5x or more, 2x or more, 3x or more, 5x or more, 7x or more, 10x or more, 15x or more, or 20x or more of the concentrations of the components in the media exemplified above, or 100x or less, 70x or less, 50x or less, 30x or less, 20x or less, 15x or less, 10x or less, 7x or less, 5x or less, 3x or less, 2x or less, or any compatible combination thereof. The concentration of each component, such as an active ingredient, in the feed medium or perfusion medium may be, for example, 1 to 2 times, 1.1 to 2 times, 1.3 to 2 times, 1.5 to 2 times, 2 to 3 times, 3 to 5 times, 5 to 7 times, 7 to 10 times, 10 to 15 times, 15 to 20 times, 20 to 30 times, 20 to 50 times, 20 to 70 times, or 20 to 100 times the concentration of the component in the medium exemplified above. The concentration of each component, such as an active ingredient, in the feed medium or perfusion medium may be, for example, 1 to 100 times, 2 to 50 times, or 5 to 20 times the concentration of the component in the medium exemplified above.

The concentrations of the various components, such as the active ingredient, can be measured by any method known in the art for detecting or identifying compounds, such as HPLC, UPLC, LC/MS, GC/MS, and NMR.

Animal cells can be cultured as described above. In one embodiment, a product (e.g., cultured meat or a target substance) may be obtained by culturing animal cells as described above. When the target substance is produced, the target substance may accumulate in the culture, for example, in the medium, on the cell surface, inside the cells, or a combination thereof. The target substance may be recovered from the culture as appropriate. That is, the method for producing a target substance may further include a step of recovering the target substance.

<4> Use of the active ingredient The present invention also discloses the use of the active ingredient in the above-mentioned applications. That is, the present invention discloses, for example, the use of the active ingredient for culturing animal cells, the use of the active ingredient for improving the growth of animal cells, and the use of the active ingredient in the manufacture of the composition of the present invention, such as a composition for animal cell culture.

The present invention also discloses active ingredients for use in the applications exemplified above. That is, the present invention discloses, for example, active ingredients for use in culturing animal cells, active ingredients for use in improving the growth of animal cells, and active ingredients for use in producing compositions for culturing animal cells.

The present invention will now be described in more detail with reference to the following non-limiting examples.

(1) Evaluation of the activity of soy lecithin using bovine muscle stem cells in serum-free medium (1-1) Preparation of bovine muscle stem cells Muscle tissue was collected from edible bovine shank meat, and CD56-positive cells were isolated using a magnetic activated cell sorting system (MACS) to prepare bovine muscle stem cells.

(1-2) Activity evaluation of soybean lecithin using bovine muscle stem cells in serum-free medium The bovine muscle stem cells obtained in (1-1) were suspended in serum medium. The serum medium used was Advanced DMEM (Thermo Fisher Scientific, Cat No. 12491015) supplemented with 20% FBS (Thermo Fisher Scientific, Cat No. 10270106), 10% horse serum (Thermo Fisher Scientific, Cat No. 16050-130), and 1% GlutaMAX ^TM Supplement (Thermo Fisher Scientific, Cat No. 35050061). The cell suspension was seeded on a 6-well plate (BD FALCON, Cat #353046) coated with 1 μg/cm ² fibronectin (Corning, Cat #F2006) to a cell density of 5300 cells/2 mL/cm ² , and the medium was replaced every other day. On the fourth day of culture, the cells were subcultured in serum-free medium or serum-free medium containing soybean lecithin, and the medium was replaced every other day. The serum-free medium used was ^StemFit® Basic03 (Ajinomoto) supplemented with 5 ng/mL HGF (Peprotech, Cat#294HGN005), 20 ng/mL EGF (Sigma, Cat#E9644), 10 ng/mL bFGF (Peprotech, Cat#AF-450-62), and Bacto™ Yeast Extract (Thermo Fisher Scientific, Cat No. 212750). The serum-free medium containing soybean lecithin was prepared by adding 10 mg/L soybean lecithin (Nacalai Tesque, Cat#20335-52), 10 mg/L soybean lecithin (Tsuji Oil Mills, product name: SLP-White), or 10 mg/L α-glycerophosphatidylcholine (αGPC) (Bioactives Japan, product name: GlycerophosphatidylCholine) to the serum-free medium. Table 1 shows the group numbers and media. Cell counts and subculture were performed every 4 days, and the proliferation rates of the two consecutive subcultures from the 4th to the 12th day were calculated.

The results are shown in Figures 1 and 2. 10 mg/L soybean lecithin (Nacalai Tesque) and 10 mg/L soybean lecithin (Tsuji Oil Mills) were found to promote the proliferation of bovine muscle stem cells, but αGPC was not found to promote the proliferation of bovine muscle stem cells.

(1-3) Activity evaluation of combinations of pea soy sauce, pea protein, and soy lecithin Bovine muscle stem cells obtained in (1-1) were suspended in serum medium. The serum medium was as described in (1-2). The cell suspension was seeded on a 6-well plate coated with 1 μg/cm ² fibronectin at a cell density of 4200 cells/2 mL/cm ² , and the medium was replaced every other day. On the fourth day of culture, the cells were passaged in serum-free medium or serum-free medium containing pea-derived substances, and the medium was replaced every other day. The serum-free medium used was StemFit ^R Basic03 (Ajinomoto) supplemented with 10 ng/mL bbFGF, 20 ng/mL EGF, and 5 ng/mL HGF. The serum-free medium containing pea-derived substances was prepared by adding 0.33% pea soy sauce (San-J, product name: No Soy Gluten Free Tamari), 2.5 g/L pea protein (Roquette, product name: NUTRALYS S85F), 2.5 g/L pea protein (HENGYUAN BIOTECHNOLOGY, product name: HYPP-A85%), 0.33% pea soy sauce and 2.5 g/L pea protein, or 0.33% pea soy sauce, 2.5 g/L pea protein, and soy lecithin (Tsuji Oil Mills, product name: SLP-White) to the serum-free medium. Table 2 shows the group numbers and media. Cell counts and subculture were performed every 4 days, and the growth rates of two consecutive subcultures from the 4th to the 12th day were calculated.

The results are shown in Figures 3 and 4. The combination of pea sauce and pea protein significantly promoted cell proliferation. Furthermore, the combination of pea sauce, pea protein, and soy lecithin further promoted cell proliferation.

Claims (27)

A method for culturing animal cells, comprising:
The composition, wherein the animal is a meat animal. The composition according to claim 1, which is a composition for improving the growth of animal cells. The composition according to claim 1 or 2, which is a medium or a medium additive. The composition of claim 3, wherein the medium is a basal medium, a feed medium, or a perfusion medium. The composition according to claim 1 or 2, wherein the lecithin is soy lecithin. The composition according to claim 1 or 2, further comprising a pea-derived material. The composition according to claim 6, wherein the pea-derived material is a pea fermentation product and/or a pea protein. The composition of claim 7, wherein the fermented pea product is pea sauce. The composition of claim 1 or 2, wherein the animal is a mammal, a bird, a fish, or a crustacean. The composition according to claim 1 or 2, wherein the animal is a cow. The composition according to claim 1 or 2, which is substantially free of serum. The composition according to claim 1 or 2, which is substantially free of animal-derived albumin. A method for producing a product, comprising the steps of:
Cultivating animal cells in the presence of lecithin,
The method, wherein the animal is a meat animal. The method of claim 13, wherein the product is cultured meat. 1. A method for culturing animal cells, comprising the steps of:
Cultivating animal cells in the presence of lecithin,
The method, wherein the animal is a meat animal. 1. A method for enhancing growth of an animal cell, comprising:
Cultivating animal cells in the presence of lecithin,
The method, wherein the animal is a meat animal. The method according to any one of claims 13 to 16, wherein the lecithin is soybean lecithin. The method according to any one of claims 13 to 16, wherein the concentration of the lecithin in the culture medium during the culture is 0.1 to 100 μg/mL. The method according to any one of claims 13 to 16, wherein the culturing is carried out in the presence of pea-derived material. The method of claim 19, wherein the pea-derived material is a fermented pea product and/or a pea protein. The method of claim 20, wherein the fermented pea product is pea sauce. The method according to claim 20, wherein the concentration of the pea fermentate in the culture medium during the culture is 0.1 to 100 mg/mL. The method according to claim 20, wherein the concentration of the pea protein in the culture medium during the culture is 0.05 to 50 mg/mL. The method according to any one of claims 13 to 16, wherein the animal is a mammal, a bird, a fish, or a crustacean. The method according to any one of claims 13 to 16, wherein the animal is a cow. The method according to any one of claims 13 to 16, wherein the culture is carried out in a medium that is substantially free of serum. The method according to any one of claims 13 to 16, wherein the culture is carried out in a medium that is substantially free of animal-derived albumin.

Images